Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger J Mills

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2010
The relationship between fatigue and other clinical features of multiple sclerosisRoger J Mills, Carolyn A Young
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 6, 2025
EQ-5D-5L in multiple sclerosis: Estimated utility values, minimal (clinically) important changes, and direct and indirect influences over timeCarolyn A Young, Roger J Mills, Alan Tennant, et al.
Health and Quality of Life Outcomes|February 16, 2010
Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS)Roger J Mills, Carolyn A Young, Julie F Pallant, et al.
Multiple Sclerosis and Related Disorders|June 26, 2025
Is multiple sclerosis a length-dependent central axonopathy? Some empirical data from the TONiC studyRoger J Mills, Daniela K Schlüter, Peter J Diggle, et al.
BMC Neurology|August 27, 2016
Urgent referral for suspected CNS cancer: which clinical features are associated with a positive predictive value of 3 % or more?Hasan Raza Mohammad, Jeremy Boardman, Laura Howell, et al.
Muscle & Nerve|May 2, 2024
Rasch analysis of the Unidimensional Self-Efficacy Scale in Neuromuscular Disorders and comparison between sex, age, and diagnosesJoshua P J Fulton, James K L Holt, Roger J Mills, et al.
Muscle & Nerve|July 2, 2024
Rasch analysis of the modified Fatigue Severity Scale in neuromuscular disorders and comparison between sex, age and diagnosesJoshua P J Fulton, James K L Holt, Roger J Mills, et al.
Die Rehabilitation|December 14, 2022
[Psychometric Evaluation of the 'German Neurological Fatigue Index for Multiple Sclerosis (NFI-MS-G)' in a Sample of Rehabilitation Patients with Multiple Sclerosis]Barbara Seebacher, Mike C Horton, Markus Reindl, et al.
Multiple Sclerosis and Related Disorders|November 6, 2023
Multiple Sclerosis vision questionnaire (MSVQ-7): Reliability, validity, precision and discriminationCarolyn A Young, David J Rog, Radu Tanasescu, et al.
Health and Quality of Life Outcomes|May 17, 2012
Validation of the Neurological Fatigue Index for stroke (NFI-Stroke)Roger J Mills, Julie F Pallant, Maria Koufali, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2010
The relationship between fatigue and other clinical features of multiple sclerosisRoger J Mills, Carolyn A Young
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 6, 2025
EQ-5D-5L in multiple sclerosis: Estimated utility values, minimal (clinically) important changes, and direct and indirect influences over timeCarolyn A Young, Roger J Mills, Alan Tennant, et al.
Health and Quality of Life Outcomes|February 16, 2010
Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS)Roger J Mills, Carolyn A Young, Julie F Pallant, et al.
Multiple Sclerosis and Related Disorders|June 26, 2025
Is multiple sclerosis a length-dependent central axonopathy? Some empirical data from the TONiC studyRoger J Mills, Daniela K Schlüter, Peter J Diggle, et al.
BMC Neurology|August 27, 2016
Urgent referral for suspected CNS cancer: which clinical features are associated with a positive predictive value of 3 % or more?Hasan Raza Mohammad, Jeremy Boardman, Laura Howell, et al.
Muscle & Nerve|May 2, 2024
Rasch analysis of the Unidimensional Self-Efficacy Scale in Neuromuscular Disorders and comparison between sex, age, and diagnosesJoshua P J Fulton, James K L Holt, Roger J Mills, et al.
Muscle & Nerve|July 2, 2024
Rasch analysis of the modified Fatigue Severity Scale in neuromuscular disorders and comparison between sex, age and diagnosesJoshua P J Fulton, James K L Holt, Roger J Mills, et al.
Die Rehabilitation|December 14, 2022
[Psychometric Evaluation of the 'German Neurological Fatigue Index for Multiple Sclerosis (NFI-MS-G)' in a Sample of Rehabilitation Patients with Multiple Sclerosis]Barbara Seebacher, Mike C Horton, Markus Reindl, et al.
Multiple Sclerosis and Related Disorders|November 6, 2023
Multiple Sclerosis vision questionnaire (MSVQ-7): Reliability, validity, precision and discriminationCarolyn A Young, David J Rog, Radu Tanasescu, et al.
Health and Quality of Life Outcomes|May 17, 2012
Validation of the Neurological Fatigue Index for stroke (NFI-Stroke)Roger J Mills, Julie F Pallant, Maria Koufali, et al.
Pageof 3